The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collaboration with Quantum Solutions

14 Nov 2008 07:00

RNS Number : 1344I
Fulcrum Pharma PLC
14 November 2008
 



FULCRUM PHARMA PLC 

Fulcrum Pharma and Quantum Solutions India form strategic collaboration to deliver high quality, high capacity drug safety services 

Fulcrum Pharma plc (AIM: FUL), the Professional Services company is pleased to announce a strategic collaboration with Quantum Solutions India in the field of drug safety. 

Fulcrum Pharma is committed to providing clients with expert solutions in pharmacovigilance for both pre- and post-marketed products. The collaboration brings together Fulcrum Pharma's expertise in strategic and operational pharmacovigilance and Quantum's expertise in delivering high quality ICSR and PSUR processing. 

The two companies will offer creative pharmacovigilance solutions in a cost-effective and tailored approach to new and existing clients. Quantum and Fulcrum Pharma believe that together they are positioned to deliver effective safety solutions to clients using a cost-leadership model coupled with excellence in execution and a proven track record in quality & compliance. 

Under the terms of the collaboration the companies will pool expertise and resources and establish a joint sales and marketing campaign in Europe and North America. Both companies, however, remain legally and operationally independent. 

Speaking of the newly forged strategic collaboration, Frank Armstrong, Chief Executive of Fulcrum Pharma, said: "Together we will be in a position to meet the increasing demand for pharmacovigilance services. The collaboration with Quantum will increase our capacity to deliver key safety products to our clients and enhance the reach of our business. We look forward to working together to develop solutions for our clients." 

Apurva Goswamy, Chief Executive of Quantum Solutions, said. "This collaboration will provide tailored solutions to meet our customers' needs, combining the strategic and operational skills of Fulcrum Pharma with the operational expertise of Quantum Solutions. Working with Fulcrum Pharma will enable us to enhance our drug safety product offering in a way that directly benefits our clients. This is an exciting opportunity for both Quantum and Fulcrum" 

For further information, please contact: 

Fulcrum Pharma PLC

Dr Frank M. Armstrong, Chief Executive  Tel: 01442 283600

Dr Phil Birch, General Manager (Europe) Tel: 01442 283600

About Fulcrum Pharma plc 

Fulcrum Pharma plc is a professional services company providing clients with expert solutions for the development of therapeutic products. Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange having successfully floated in March 2000. 

About Quantum Solutions India

Quantum Solutions India is a highly-reputed quality-driven contract research organization serving the pharmaceutical industry, and specializing in drug safety. Its highly qualified, professional, English-speaking staff supported by a robust IT infrastructure ensure very high standards of service delivery.

___________________________

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAILFEELVLVLIT
Date   Source Headline
16th Mar 20202:00 pmRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSHalf-year Report
2nd Dec 20197:00 amRNSNotice of Interim Results
30th Aug 201912:40 pmRNSCompletion of purchase of minority interests
28th Aug 20195:45 pmRNSResult of AGM
28th Aug 20197:00 amRNSAGM Statement and Trading Update
19th Aug 20197:00 amRNSGrant of options
8th Aug 20197:00 amRNSDirector Shareholding
6th Aug 20197:00 amRNSDirector shareholding
5th Aug 20193:26 pmRNSPosting of Accounts and Notice of AGM
31st Jul 20195:00 pmRNSTotal Voting Rights
23rd Jul 20194:42 pmRNSExercise of options and Director shareholdings
17th Jul 20197:00 amRNSHolding(s) in Company
16th Jul 20197:00 amRNSFinal Results
16th Jul 20197:00 amRNSProposed acquisition of minority interests in subs
27th Jun 20194:41 pmRNSSecond Price Monitoring Extn
27th Jun 20194:35 pmRNSPrice Monitoring Extension
28th Mar 20197:00 amRNSYear End Trading Update
7th Jan 20193:40 pmRNSDirector/PDMR Shareholding
12th Dec 20187:00 amRNSHalf-year Report
7th Nov 20187:00 amRNSTrading Update and Notice of Interim Results
2nd Oct 201811:00 amRNSPrice Monitoring Extension
12th Sep 201811:58 amRNSDirector/PDMR Shareholding
24th Aug 20187:00 amRNSDirector/PDMR Shareholding
23rd Aug 201811:36 amRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement and Trading Update
9th Aug 20183:47 pmRNSDirector/PDMR Shareholding
1st Aug 20184:07 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20181:58 pmRNSDirector/PDMR Shareholding
25th Jul 20185:00 pmRNSGrant of options
24th Jul 20187:00 amRNSFinal Results
13th Jul 201810:22 amRNSNotice of Results
11th Apr 20184:40 pmRNSSecond Price Monitoring Extn
11th Apr 20184:35 pmRNSPrice Monitoring Extension
12th Mar 20182:05 pmRNSSecond Price Monitoring Extn
12th Mar 20182:00 pmRNSPrice Monitoring Extension
8th Mar 20183:36 pmRNSTrading Statement
16th Jan 201810:05 amRNSDirector Shareholding
15th Dec 20177:00 amRNSHalf-year Report
4th Oct 20177:00 amRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSHolding(s) in Company
7th Sep 20176:00 pmRNSPDMR Shareholding
7th Sep 201712:15 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSDirector/PDMR Shareholding
6th Sep 201712:47 pmRNSResult of AGM
6th Sep 201712:40 pmRNSDirector/PDMR Shareholding
6th Sep 20177:00 amRNSAGM Statement and trading update
16th Aug 20179:20 amRNSPosting of Annual Report and Notice of AGM
31st Jul 201711:35 amRNSGrant of options
12th Jul 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.